SDF-1 and neurogenesis in HIV-1 associated dementia

SDF-1 和 HIV-1 相关痴呆的神经发生

基本信息

项目摘要

DESCRIPTION (provided by applicant): Neural progenitor cells (NPC) are present throughout life and replenish neurons and glia (astrocytes and oligodendrocytes) through neurogenesis, a process that requires proper migration, proliferation and differentiation of NPC. Neurogenesis appears to be dysfunctional in neurodegenerative disorders including HIV-1 associated dementia (HAD), Alzheimer's and Parkinson's diseases, where dead or injured neurons are not replaced. HAD is a neurodegenerative disorder where HIV-1-infected and activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) mediate inflammatory conditions that alter brain homeostasis. We recently demonstrated that HIV-1-infected and activated macrophages inhibit neurogenesis but enhance gliogenesis. We propose this gliogenesis is mediated through brain inflammation attributable to the dysregulation of stromal cell-derived factor 1 (SDF-1). SDF-1 is an endogenous ligand for the chemokine receptor, CXCR4, which is highly expressed on human NPC and mediates NPC migration. Improper SDF-1 and CXCR4 function can affect neural repair by impairing NPC migration. SDF-1 is released in response to glial activation, mediated by inflammatory cytokines from HIV-1-infected and activated MP such as Interleukin one beta (IL-12). SDF-1 is elevated in the cerebrospinal fluid of HAD patients. Activated matrix metalloproteinase-2 (MMP-2) is produced by HIV-1 infected and activated MP and cleaves SDF-1 resulting in a neurotoxic fragment. This proposal will examine the role of HIV-1-infected and activated macrophage in brain inflammation and their effects on neurogenesis. We hypothesize HIV-1-infected and immune- activated MP inhibit neuronal differentiation and promote gliogenesis. Specifically, we propose this shift in neurogenesis is dependent upon SDF-1 produced by activated astrocytes. This gliogenesis may be a consequence of modification/degradation of SDF-1 by factors released from HIV-1-infected MP leading to impairment of normal SDF-1/CXCR4 mediated NPC migration, survival, proliferation and differentiation, generating an environment detrimental to CNS repair. Using our human NPC culture system in a severe combined immune deficient (SCID) HIV-1 encephalitis (HIVE) mouse model, this project will mimic HIV-1-infection and immune-activation of brain MP and investigate the effect of CNS inflammation on neurogenesis. Elucidating the mechanisms of SDF-1/CXCR4 influence on neurogenesis may identify new therapeutic strategies for treating HAD and other neurodegenerative disorders. PUBLIC HEALTH RELEVANCE Globally, about 40 million people are infected with HIV. 10-20% of these individuals will eventually develop HIV-associated dementia (HAD). This work will elucidate mechanisms through which neurogenesis is affected by HAD, which could identify new therapeutic strategies for treating HAD and other neurodegenerative disorders.
描述(由申请人提供):神经祖细胞(NPC)存在于整个生命过程中,并通过神经发生补充神经元和神经胶质细胞(星形胶质细胞和少突胶质细胞),这是一个需要NPC适当迁移、增殖和分化的过程。神经发生似乎在神经退行性疾病中功能障碍,包括HIV-1相关痴呆(HAD),阿尔茨海默病和帕金森病,其中死亡或受伤的神经元没有被替换。HAD是一种神经退行性疾病,其中HIV-1感染和激活的脑单核吞噬细胞(MP;血管周围巨噬细胞和小胶质细胞)介导改变脑内稳态的炎性病症。我们最近发现,HIV-1感染和激活的巨噬细胞抑制神经发生,但增强胶质细胞的生成。我们提出这种胶质细胞生成是通过脑炎症介导的,可归因于基质细胞衍生因子1(SDF-1)的失调。SDF-1是趋化因子受体CXCR 4的内源性配体,CXCR 4在人NPC上高度表达并介导NPC迁移。不适当的SDF-1和CXCR 4功能可以通过损害NPC迁移来影响神经修复。SDF-1在神经胶质细胞活化时释放,由HIV-1感染和活化MP的炎性细胞因子如白细胞介素1 β(IL-12)介导。SDF-1在HAD患者的脑脊液中升高。活化的基质金属蛋白酶-2(MMP-2)由HIV-1感染和活化的MP产生,并切割SDF-1,产生神经毒性片段。这项建议将研究HIV-1感染和激活的巨噬细胞在脑炎症中的作用及其对神经发生的影响。我们假设HIV-1感染和免疫激活的MP抑制神经元分化并促进胶质细胞生成。具体来说,我们提出这种神经发生的转变依赖于活化的星形胶质细胞产生的SDF-1。这种胶质细胞生成可能是由HIV-1感染的MP释放的因子修饰/降解SDF-1的结果,导致正常SDF-1/CXCR 4介导的NPC迁移、存活、增殖和分化受损,产生对CNS修复有害的环境。利用我们的人NPC培养系统在严重联合免疫缺陷(SCID)HIV-1脑炎(HIVE)小鼠模型中,本项目将模拟HIV-1感染和脑MP的免疫激活,并研究CNS炎症对神经发生的影响。阐明SDF-1/CXCR 4影响神经发生的机制可能会为治疗HAD和其他神经退行性疾病找到新的治疗策略。全球约有4000万人感染艾滋病毒。这些人中有10-20%最终会发展为艾滋病毒相关性痴呆(HAD)。这项工作将阐明神经发生受HAD影响的机制,这可以确定治疗HAD和其他神经退行性疾病的新治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jialin Charles Zheng其他文献

Jialin Charles Zheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jialin Charles Zheng', 18)}}的其他基金

Glutaminase and its neurotoxic link to HAND
谷氨酰胺酶及其与 HAND 的神经毒性联系
  • 批准号:
    9357733
  • 财政年份:
    2016
  • 资助金额:
    $ 36.75万
  • 项目类别:
Glutaminase and its neurotoxic link to HAND
谷氨酰胺酶及其与 HAND 的神经毒性联系
  • 批准号:
    9146113
  • 财政年份:
    2016
  • 资助金额:
    $ 36.75万
  • 项目类别:
ACTIVITY MODULATION OF PROTEIN KINASE AND PHOSPHATASE
蛋白激酶和磷酸酶的活性调节
  • 批准号:
    8362286
  • 财政年份:
    2011
  • 资助金额:
    $ 36.75万
  • 项目类别:
ACTIVITY MODULATION OF PROTEIN KINASE AND PHOSPHATASE
蛋白激酶和磷酸酶的活性调节
  • 批准号:
    8170287
  • 财政年份:
    2010
  • 资助金额:
    $ 36.75万
  • 项目类别:
CELLULAR MECHANISMS FOR HIV 1 INDUCED NEURONAL INJURY
HIV 1 引起的神经元损伤的细胞机制
  • 批准号:
    7959385
  • 财政年份:
    2009
  • 资助金额:
    $ 36.75万
  • 项目类别:
SDF-1 and neurogenesis in HIV-1 associated dementia
SDF-1 和 HIV-1 相关痴呆的神经发生
  • 批准号:
    7869501
  • 财政年份:
    2008
  • 资助金额:
    $ 36.75万
  • 项目类别:
SDF-1 and neurogenesis in HIV-1 associated dementia
SDF-1 和 HIV-1 相关痴呆的神经发生
  • 批准号:
    7647340
  • 财政年份:
    2008
  • 资助金额:
    $ 36.75万
  • 项目类别:
HIV-1 Clade Diversity and Macrophage Mediated Neurotoxicity in HIV-1 Dementia
HIV-1 进化枝多样性和巨噬细胞介导的 HIV-1 痴呆神经毒性
  • 批准号:
    7612649
  • 财政年份:
    2008
  • 资助金额:
    $ 36.75万
  • 项目类别:
SDF-1 and neurogenesis in HIV-1 associated dementia
SDF-1 和 HIV-1 相关痴呆的神经发生
  • 批准号:
    8026004
  • 财政年份:
    2008
  • 资助金额:
    $ 36.75万
  • 项目类别:
SDF-1 and neurogenesis in HIV-1 associated dementia
SDF-1 和 HIV-1 相关痴呆的神经发生
  • 批准号:
    8266024
  • 财政年份:
    2008
  • 资助金额:
    $ 36.75万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了